Zapizolam
Clinical data | |
---|---|
ATC code |
|
Identifiers | |
IUPAC name
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.058.774 |
Chemical and physical data | |
Formula | C15H9Cl2N5 |
Molar mass | 330.171 g·mol−1 |
3D model (JSmol) | |
SMILES
| |
InChI
| |
(verify) |
Zapizolam[1] is a pyridodiazepine drug, which is a benzodiazepine analog[2] of pyridotriazolodiazepine group. It has sedative and anxiolytic effects similar to those produced by benzodiazepine derivatives, and has been sold illicitly as a designer drug.[3]
References
- ↑ DE Withdrawn 2649116, Von Bebenburg W, Schulmeyer N, Jakovlev V, "Neue 6-aryl-s-triazolo-(4,3-a)- pyrido-(2,3-f)-1,4-diazepine", published 18 May 1977, assigned to Evonik Operations GmbH
- ↑ "Chemical Book" (in Chinese).
- ↑ Zawilska JB, Wojcieszak J (July 2019). "An expanding world of new psychoactive substances-designer benzodiazepines". Neurotoxicology. 73: 8–16. doi:10.1016/j.neuro.2019.02.015. PMID 30802466.
This article is issued from Offline. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.